United States Non-alcoholic Steatohepatitis Therapeutic & Diagnostic Market Poised for Growth Through Next-Generation Therapies
  The United States holds a leading position in the Non-alcoholic Steatohepatitis Therapeutic & Diagnostic Market, driven by the high prevalence of obesity, type 2 diabetes, and metabolic syndrome, which are major risk factors for liver disease. The country benefits from a strong healthcare infrastructure, significant investments in liver disease research, and the presence of leading...
0 Kommentare 0 Geteilt 53 Ansichten 0 Bewertungen